In prostate cancer cells, ERG recruits the AR at the level of novel genetic loci and interacts with other transcription factors at the level of AR binding sites, and, through these effects, modifies the transcriptional activity induced by androgen signaling. Here, ERG is linked to prostate carcinoma.